Clinical Trial Update: Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical study evaluating safety and efficacy of bone marrow mononuclear cells (BMMNC) in patients with cerebellar ataxia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebellar Ataxia

Drugs mentioned

• BMMNC (bone marrow mononuclear cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Cerebellar Ataxia | Phase 1, Phase 2 | Status: UNKNOWN